Lucia D’Amico - Concepedia

Author

Lucia D’Amico

University of Turin

Also Known As

D'Amico L., L D'Amico, L D′Amico, L. D'Amico, L. D’Amico, LUCIA D’AMICO, Lucia D'Amico, Lucia D’Amico

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of Turin Azienda Ospedaliero Universitaria San Giovanni Battista Azienda Ospedaliera Citta' della Salute e della Scienza di Torino Candiolo Cancer Institute University of Basel

About

Lucia D’Amico is an author at University of Turin specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	445
2	Cell Biology	6	6	337
3	Immunology	6	6	320
4	Health Sciences	1	1	10
5	Neurology	1	1	10

Lucia D’Amico

Publications

Citations

H-Index

Page 1

	Year	Citations
Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer Lucia D’Amico, Sahil Mahajan, Aude-Hélène Capietto, The Journal of Experimental Medicine	2016	150
A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer Lucia D’Amico, Ulrike Menzel, Michael Prummer, Journal for ImmunoTherapy of Cancer Breast OncologyPd-1 BlockadeAdaptive Immune SystemImmunologyImmune Regulation	2019	116
Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM− Lung Cancer–Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis Giulia Bertolini, Lucia D’Amico, Massimo Moro, Cancer Research Cancer ImmunosurveillanceMedicineImmunologyBiological MicroenvironmentsCancer Cell Biology	2015	96
Bone Impairment in Phenylketonuria Is Characterized by Circulating Osteoclast Precursors and Activated T Cell Increase Ilaria Roato, Francesco Porta, Alessandro Mussa, PLoS ONE	2010	56
Efficacy of a Cancer Vaccine against <i>ALK</i> -Rearranged Lung Tumors Claudia Voena, Matteo Menotti, Cristina Mastini, Cancer Immunology Research	2015	56
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL Francesco Boccalatte, Claudia Voena, Chiara Riganti, Blood	2008	52
The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models Heinz Läubli, Philipp Müller, Lucia D’Amico, Cancer Immunology Immunotherapy Tumor-induced ImmunosuppressionMulti-receptor InhibitorImmune-modulatory AntibodiesMedicineImmunology	2018	50
Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures Patrizia D’Amelio, Ilaria Roato, Lucia D’Amico, Osteoporosis International InflammationBone DiseaseCell DeathFracture HealingOsteoporosis Fragility Fractures	2010	49
Bone invading NSCLC cells produce IL-7: mice model and human histologic data Ilaria Roato, Davide Caldo, Laura Godio, BMC Cancer	2010	45
Cross-talk between T cells and osteoclasts in bone resorption Lucia D’Amico, Ilaria Roato BoneKEy Reports	2012	44

Page 1